Search Results - "Claeys, Kimberly"

Refine Results
  1. 1

    Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections by Smith, Jordan R., Rybak, Jeffrey M., Claeys, Kimberly C.

    Published in Pharmacotherapy (01-04-2020)
    “…Imipenem‐cilastatin‐relebactam (IMI‐REL) is a novel β‐lactam–β‐lactamase inhibitor combination recently approved for the treatment of complicated urinary tract…”
    Get full text
    Journal Article
  2. 2

    The Diagnosis and Treatment of Adult Urinary Tract Infections in the Emergency Department by Redwood, Robert, Claeys, Kimberly C.

    “…Emergency medicine has been called the art of “making complicated clinical decisions with limited information.” This description is particularly relevant in…”
    Get full text
    Journal Article
  3. 3

    Behavioral Strategies in Diagnostic Stewardship by Advani, Sonali D., Claeys, Kimberly

    “…Diagnostic stewardship refers to the responsible and judicious use of diagnostic tests to reduce low value care and improve patient outcomes. This article…”
    Get full text
    Journal Article
  4. 4

    Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections by Zasowski, Evan J., Claeys, Kimberly C., Lagnf, Abdalhamid M., Davis, Susan L., Rybak, Michael J.

    Published in Clinical infectious diseases (15-05-2016)
    “…Background. With increasing prevalence of vancomycin-resistant enterococci (VRE), appropriate antibiotic therapy for enterococcal bloodstream infections (EBSI)…”
    Get full text
    Journal Article
  5. 5

    The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms by Noval, Mandee, Banoub, Mary, Claeys, Kimberly C., Heil, Emily

    Published in Current infectious disease reports (13-01-2020)
    “…Purpose of Review Resistant gram-negative infections are becoming increasingly difficult to treat, prompting increased focus on drug development. This review…”
    Get full text
    Journal Article
  6. 6

    Leveraging diagnostic stewardship within antimicrobial stewardship programmes by Claeys, Kimberly C, Johnson, Melissa D

    Published in Drugs in Context (20-02-2023)
    “…Novel diagnostic stewardship in infectious disease consists of interventions that modify ordering, processing, and reporting of diagnostic tests to provide the…”
    Get full text
    Journal Article
  7. 7

    Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis by Claeys, Kimberly C, Schlaffer, Kathryn, Smith, Richard, Hitchcock, Stephanie, Jiang, Yunyun, Evans, Scott, Johnson, J Kristie, Leekha, Surbhi

    Published in Clinical infectious diseases (15-09-2021)
    “…Abstract Three rapid diagnostic test panels (Verigene BC-GN, BioFire BCID, and BCID 2 [RUO]) were compared using the Desirability of Outcome Ranking Management…”
    Get full text
    Journal Article
  8. 8

    Implementing diagnostic stewardship to improve diagnosis of urinary tract infections across three medical centers: A qualitative assessment by Claeys, Kimberly C., Weston, Lauren E., Pineles, Lisa, Morgan, Daniel J., Krein, Sarah L.

    “…Urine-culture diagnostic stewardship aims to decrease misdiagnosis of urinary tract infections (UTIs); however, these interventions are not widely adopted. We…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Diagnostic and antimicrobial stewardship with molecular respiratory testing across the SHEA Research Network by Claeys, Kimberly C., Morgan, Daniel J., Leekha, Surbhi, Sullivan, Kaede V.

    “…This survey investigated diagnostic and antimicrobial stewardship practices related to molecular respiratory panel testing in adults with lower respiratory…”
    Get full text
    Journal Article
  12. 12

    Does calculation method matter for targeting vancomycin area under the curve? by Chang, Jack, Patel, Dhara, Vega, Ana, Claeys, Kimberly C, Heil, Emily L, Scheetz, Marc H

    Published in Journal of antimicrobial chemotherapy (28-07-2022)
    “…Abstract Objectives To assess differences in vancomycin AUC estimates from two common, clinically applied first-order pharmacokinetic equation methods compared…”
    Get full text
    Journal Article
  13. 13
  14. 14

    An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities by Pogue, Jason M, Heil, Emily L, Lephart, Paul, Johnson, J Kristie, Mynatt, Ryan P, Salimnia, Hossein, Claeys, Kimberly C

    Published in Antimicrobial agents and chemotherapy (01-05-2018)
    “…Rapid diagnostic tests (RDTs) have revolutionized the management of Gram-negative bacteremia by allowing antimicrobial stewardship teams the ability to…”
    Get full text
    Journal Article
  15. 15

    Diagnostic stewardship: what impacts antibiotics use? by Coffey, KC, Morgan, Daniel J, Claeys, Kimberly C

    Published in Current opinion in infectious diseases (01-08-2023)
    “…The aim of this study was to review recently published diagnostic stewardship studies of common clinical infectious syndromes and the impact on antibiotic…”
    Get full text
    Journal Article
  16. 16

    Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis by Casapao, Anthony M, Lodise, Thomas P, Davis, Susan L, Claeys, Kimberly C, Kullar, Ravina, Levine, Donald P, Rybak, Michael J

    Published in Antimicrobial agents and chemotherapy (01-06-2015)
    “…Given the critical importance of early appropriate therapy, a retrospective cohort (2002 to 2013) was performed at the Detroit Medical Center to evaluate the…”
    Get full text
    Journal Article
  17. 17

    Advances and Challenges in the Diagnosis and Treatment of Urinary Tract Infections: the Need for Diagnostic Stewardship by Claeys, Kimberly C., Blanco, Natalia, Morgan, Daniel J., Leekha, Surbhi, Sullivan, Kaede V.

    Published in Current infectious disease reports (01-04-2019)
    “…Purpose of Review Urinary tract infections (UTIs), including catheter-associated UTIs, are among the most common bacterial infections in both inpatient and…”
    Get full text
    Journal Article
  18. 18

    No Crystal Ball? Using Risk Factors and Scoring Systems to Predict Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) and Carbapenem-Resistant Enterobacterales (CRE) Infections by Li, Cecilia, Claeys, Kimberly C., Justo, Julie A., Heil, Emily L.

    Published in Current infectious disease reports (01-11-2022)
    “…Purpose of Review Predicting whether a hospitalized patient is infected with an ESBL-E or CRE remains challenging and often leads to overutilization of…”
    Get full text
    Journal Article
  19. 19

    Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections by Zasowski, Evan J, Trinh, Trang D, Claeys, Kimberly C, Casapao, Anthony M, Sabagha, Noor, Lagnf, Abdalhamid M, Klinker, Kenneth P, Davis, Susan L, Rybak, Michael J

    Published in Antimicrobial agents and chemotherapy (01-02-2017)
    “…Novel therapies for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) are needed in the setting of reduced antibiotic…”
    Get full text
    Journal Article
  20. 20

    From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing by Lapin, Jonathan S., Smith, Richard D., Hornback, Krutika M., Johnson, J. Kristie, Claeys, Kimberly C.

    Published in Pharmacotherapy (01-08-2023)
    “…Antimicrobial stewardship (AMS) programs have been quick to adopt novel molecular rapid diagnostic technologies (mRDTs) for bloodstream infections (BSIs) to…”
    Get full text
    Journal Article